ArticleTranslational pediatrics2026
Novel inflammatory biomarkers and disease severity in hospitalized children with
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A resurgence of Methods: We conducted a retrospective analysis of 866 hospitalized children with MPP. For each case, we calculated the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI). Multivariable logistic regression analysis was performed to identify factors associated with severe MPP. Receiver operating characteristic (ROC) curves were used to evaluate the discriminatory performance of these biomarkers for distinguishing severe cases from non-severe MPP. Results: Compared with the non-severe group, children with severe MPP showed significantly higher levels of NLR, PLR, and SII (all P<0.001), whereas SIRI levels were lower (P=0.01). Patients with severe MPP were also older and had longer fever duration (P<0.001). In ROC analysis, SII demonstrated limited discriminatory ability for identifying severe MPP. The combination of SII and fever duration showed the highest area under the curve (AUC) among the evaluated indices. Conclusions: Elevated SII and prolonged fever duration were associated with increased disease severity in children with MPP. Although the discriminatory performance of SII alone was limited, inflammatory indices may provide additional information for clinical risk stratification when interpreted alongside clinical features. Further prospective studies are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.